Clinical Trials Directory

Trials / Completed

CompletedNCT02524054

Aerosol Inhalation Treatment for Dyspnea - Patients

Aerosol Inhalation Treatment for Dyspnea

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this protocol is to develop and test aerosol furosemide, as a treatment that has the potential to significantly improve symptom management and enhance the quality of care for patients with intractable dyspnea.

Detailed description

This is the second study in a series of studies investigating the treatment effect of aerosolized furosemide on hospitalized patients and outpatients with intractable dyspnea. The study will focus on patients who experience intractable dyspnea at rest or with minimal activity, e.g., dressing, bathing, cooking, or walking stairs or short distances. There are two parts to this study: Study 2a is a pilot study on 5-10 patients. These trials are not blinded or placebo controlled; the investigators will use them to discover practical problems, and take the information back to the laboratory to develop solutions. We enrolled 7 subjects for Study 2a. Study 2b will a randomized, placebo - controlled, double- blind study on 25 - 40 patients. The two planned treatments will be aerosolized furosemide and aerosolized saline, and will be given to each patient on two separate days. We failed to reach our enrollment goal, and ultimately enrolled 17 subjects for participation in Study 2b.

Conditions

Interventions

TypeNameDescription
DRUGFurosemide80 mg of Furosemide in 8ml saline will be aerosolized using ultrasonic screen nebulizers. Aerosol will be delivered using a clinical volume-control ventilator to regulate inspiratory flow and volume.
DRUGAerosolized saline8ml saline will be aerosolized using ultrasonic screen nebulizers. Aerosol will be delivered using a clinical volume-control ventilator to regulate inspiratory flow and volume.

Timeline

Start date
2014-11-01
Primary completion
2016-11-30
Completion
2017-12-01
First posted
2015-08-14
Last updated
2018-01-23
Results posted
2017-10-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02524054. Inclusion in this directory is not an endorsement.